Taiwan strengthens COVID-19 testing capacity with new screening & reporting systems

Taiwan |  News | 0 Comment | 03 May, 2022

The Central Epidemic Command Center (CECC) in Taiwan has launched a contact tracing self-reporting system for confirmed ...Read more

Taiwan's iXensor receives strategic investment to expand mobile health biz globally

Taiwan |  News | 0 Comment | 28 Apr, 2022

Taiwan's iXensor, the pioneer of mobile health, has announced that Rohto Pharmaceutical Co., Ltd, a multinational pharma...Read more

Orient EuroPharma gains rights to Contrave for Taiwan

Taiwan |  News | 0 Comment | 06 Apr, 2022

Orient EuroPharma has signed a deal with the US branded and generic drugmaker Currax Pharmaceuticals to bring the weight...Read more

Taiwan accepts CANbridge's NDA for Alagille Syndrome

Taiwan |  News | 0 Comment | 29 Mar, 2022

CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...Read more

Taiwan's Health2Sync partners with Novo Nordisk Pharma

Taiwan |  News | 0 Comment | 28 Mar, 2022

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate c...Read more

Lotus Pharma buys Cialis (Tadalafil) in Taiwan from Lilly for $57.5M

Taiwan |  News | 0 Comment | 24 Mar, 2022

Lotus Pharmaceuticals has acquired trademark, marketing authorization, and manufacturing know-how of Tadalafil 2.5mg, 5m...Read more

OBI Pharma enters license agreement with Odeon Therapeutics

Taiwan |  News | 0 Comment | 14 Mar, 2022

OBI Pharma, Inc. (OBI), a Taiwan biopharma company, and Odeon Therapeutics (Odeon), a China biopharma company, have ente...Read more

SOPHiA GENETICS HRD Solution makes way in Asia Pacific

Taiwan |  News | 0 Comment | 10 Mar, 2022

SOPHiA GENETICS has announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aimi...Read more

Taiwan approves Merck's KEYTRUDA in combination with Eisai's LENVIMA

Taiwan |  News | 0 Comment | 09 Mar, 2022

Eisai Co., Ltd. announced that LENVIMA® (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase i...Read more

Taiwan-based firms to develop global CDMO for inhalation treatment drugs

Taiwan |  News | 0 Comment | 07 Mar, 2022

Taiwan-based HCmed Innovations has formed a strategic alliance with Formosa Laboratories and Formosa Pharmaceuticals, In...Read more

Taiwan's ITRI to launch iPMx molecular rapid test system for COVID-19 in Japan

Taiwan |  News | 0 Comment | 01 Mar, 2022

The iPMx Molecular Rapid Test System, developed by the Industrial Technology Research Institute (ITRI) in Taiwan, with t...Read more

Taiwan approves new first-line treatment for advanced renal cell carcinoma

Taiwan |  News | 0 Comment | 31 Jan, 2022

Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...Read more

Lung cancer screening leading to over-diagnosis in Taiwan: Study

Taiwan |  News | 0 Comment | 21 Jan, 2022

A new study based on data from a national cancer registry in Taiwan found evidence that lung cancer screening may be lea...Read more

H2U raises $8M to power new health ecosystem in Taiwan

Taiwan |  News | 0 Comment | 18 Jan, 2022

Health to U (H2U) Corporation, an industry-leader in connected healthcare technology and provider of digital health and ...Read more

Eisai strengthens brain health assessment in Asia

Taiwan |  News | 0 Comment | 14 Jan, 2022

Australian firm Cogstate, via its global commercial partner Eisai has announced that Cogstate technology will be markete...Read more

Taiwan's GoldenBiotech suggests 100% recovery with oral drug Antroquinonol in COVID-19 patients

Taiwan |  News | 0 Comment | 10 Jan, 2022

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...Read more

MediBalloon establishes mass production capabilities in Taiwan

Taiwan |  News | 1 Comment | 04 Jan, 2022

US-based MediBalloon, Inc. has announced a partnership with Medeon Biodesign, Inc., a Taiwan publicly traded m...Read more

Taiwan’s Acura NanoMedicine reduces drug resistance in cancer cells

Taiwan |  News | 0 Comment | 14 Dec, 2021

Taiwanese startup Acura NanoMedicine Inc has announced a groundbreaking nanotech-based solution to reduce instances of d...Read more